Hamdy, A.K.; Sakamoto, T.; Toma, T.; Sakamoto, M.; Abourehab, M.A.S.; Otsuka, M.; Fujita, M.; Tateishi, H.; Radwan, M.O.
New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia. Pharmaceuticals 2022, 15, 1579.
https://doi.org/10.3390/ph15121579
AMA Style
Hamdy AK, Sakamoto T, Toma T, Sakamoto M, Abourehab MAS, Otsuka M, Fujita M, Tateishi H, Radwan MO.
New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia. Pharmaceuticals. 2022; 15(12):1579.
https://doi.org/10.3390/ph15121579
Chicago/Turabian Style
Hamdy, Ahmed K., Takashi Sakamoto, Tsugumasa Toma, Masaharu Sakamoto, Mohammed A. S. Abourehab, Masami Otsuka, Mikako Fujita, Hiroshi Tateishi, and Mohamed O. Radwan.
2022. "New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia" Pharmaceuticals 15, no. 12: 1579.
https://doi.org/10.3390/ph15121579
APA Style
Hamdy, A. K., Sakamoto, T., Toma, T., Sakamoto, M., Abourehab, M. A. S., Otsuka, M., Fujita, M., Tateishi, H., & Radwan, M. O.
(2022). New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia. Pharmaceuticals, 15(12), 1579.
https://doi.org/10.3390/ph15121579